Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Original Article from The New England Journal of Medicine — Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Original Article from The New England Journal of Medicine — Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
The current crisis in the United States is bigger than politics, and it deeply affects the health and lives of our patients and communities. Now…
Among patients with COPD, those with persistent or newly formed mucus plugs at 5-year follow-up had a greater decrease in lung function than those with…
Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral inflammation and persistent immune activation within the central nervous system,…
A 29-year-old woman was admitted to the hospital because of sore throat and peritonsillar swelling and bleeding. Symptoms did not abate with antimicrobial therapy. A…
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
The author describes the scientific foundations of a trial of an orexin agonist to treat narcolepsy.
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis–associated organisms between partners suggests that ma…
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
Quick Take Video Summary from The New England Journal of Medicine — Tolebrutinib versus Teriflunomide in Multiple Sclerosis